elinzanetant
Drug Details
- Generic Name
- elinzanetant
- Brand Names
- LYNKUET
- Application Number
- NDA219469
- Sponsor
- Bayer HealthCare Pharmaceuticals Inc.
- NDC Codes
- 1
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- ELINZANETANT
Indications and Usage
1 INDICATIONS AND USAGE LYNKUET is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. LYNKUET is a neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. ( 1 )